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Objectives- In a retrospective non-randomised study we assessed the outcome after in situ replacement ofinfected knitted 
Dacron abdominal aortic grafts in patients without septicaemia or retroperitoneal abscesses. We also assessed whether the 
specific bacterial infection influenced outcome. 
Materials and methods: Over the 5 years studied, 18 patients (9 with perigraft infection and 9 with aortoenteric erosion) 
underwent in situ replacement ofaortofemoral grafts. All patients were haemodynamically stable, none required emergency 
treatment. Preoperative assessment included CT, MRI, leukocyte-labelled scintigraphy, and bacterial cultures whenever 
possible. Infected grafts were totally excised and replaced in situ with standard PTFE prostheses. Bacterial diagnosis 
included intraoperative Gram-staining and postoperative graft cultures. None of the patients had retroperitoneal collections 
or proximal anastomotic dehiscence. All patients had 6 week intravenous antibiotic therapy. 
Results: One patient died of myocardial infarction, and another of haemorrhagic shock from proximal anastomotic 
dehiscence, accounting for a graft-related mortality of 6%. Dehiscence resulted from a polymicrobial infection. Mean 37 
month surveillance showed no amputations and no graft-related infections. 
Conclusions: In clinically and bacteriologically selected patients, total in situ replacement of infected abdominal aortic 
grafts offers an excellent outcome. 
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Introduction 
Infected abdominal aortic grafts rank among the most 
severe complications of vascular surgery with high 
mortality and morbidity. 1'2 The conventional proce- 
dure for their management involves excision of the 
graft, aortic ligature and restoration of lower limb 
blood flow by extra-anatomic bypass grafting. An 
alternative and more conservative approach requires 
total excision of the graft and placement of a new graft 
in the same location. Reviewing the published results 
of surgical treatment for infected prostheses in 1983, 
Bunt 3 reported that the mortality rates for the two 
operative procedures differed significantly (38% for 
excision followed by aortic ligature vs. 56% for in situ 
replacement). During recent years, graft excision and 
aortic ligature has therefore gained acceptance as the 
treatment of choice for infected abdominal aortic 
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grafts. Recently more effective correction of risk 
factors, advances in antibiotic therapy, and, possibly 
the shorter operating time achieved by completing the 
extra-anatomic revascularisation a few days before 
excision of the graft, have considerably improved 
results, so that mortality now ranges from 14 to 29%, 
and the incidence of amputation ranges from 13 to 
29% .4-9 
Despite the potential risk of reinfection by placing 
the new graft into an infected operating field, several 
investigators have reproposed in situ graft replace- 
10 13 ment for treating aortoenteric fistulae - and peri- 
graft infection. 14 In establishing the clinical criteria for 
in situ replacement, published case series agree that 
this operation has a greater likelihood of success in 
patients with localised graft infections (absence of 
septicaemia or extensive purulent retroperitoneal col- 
lections), i.e. low-grade infections. 12 In contrast, the 
bacteriological criteria underlying the indications for 
in situ replacement remain less clear, mainly because 
few study protocols in published series have included 
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preoperative, intraoperative and postoperative bacte- 
riological tests. Lack of outcome data has so far 
precluded clear indications for in situ graft replace- 
ment in patients with Gram-negative or Gram-neg- 
ative-Gram-positive infections. But ample experi- 
mental and clinical data suggest hat Pseudomonas 
infection is an absolute contraindication. 15 
In this study we retrospectively assessed outcome in 
a series of 18 patients, all of whom had low-grade 
infections, treated by in situ prosthetic-graft replace- 
ment for infected abdominal aortic grafts. 
Table 1. Incidence of symptoms in 18 patients undergoing in situ 
replacement of infected abdominal aortic grafts. 
Symptoms No. of patients (%) 
Fever 12 (67) 
Gastrointestinal bleeding 7 (39) 
melena 3 
occult faecal blood 4 
Fever+gastrointestinal bleeding 6 (33) 
Groin sinus tract 5 (42) 
Groin abscess 3 (25) 
Groin false aneurysm 3 (25) 
Weight loss (> 6 kg) 2 (11) 
Materials and Methods 
Between December 1989 and February 1995, 20 
patients were referred to the Vascular Surgery Unit at 
the University of Rome "La Sapienza', ItalN for 
treatment of infected synthetic abdominal aortic grafts 
and 18 underwent in situ replacement. Two patients 
were excluded from the management protocol because 
they had more severe clinical disease (positive blood 
cultures, septic lower-limb emboli with retroper- 
itoneal collection). Graft infections were diagnosed at 
a mean 46 months (range 6 months - 11 years) after the 
original aortic reconstruction. Of the 18 patients (17 
men and I woman, mean age 64.7 years; range 31 - 77 
years), eight (44%) had originally undergone surgery 
for occlusive arterial disease (5 at Leriche stage II and 
3 at stage III) and 10 (56%) for infrarenal aortic 
aneurysms, one a ruptured aneurysm. All repairs had 
been done under perioperative antibiotic coverage, 
with knitted Dacron grafts. Twelve patients had 
originally received aortomonofemoral or aortobife- 
moral bypass grafts; five had aortoaortic grafts and 
one an aortobiiliac graft. All patients had had an 
uncomplicated postoperative course. 
Clinical examination showed that all patients were 
haemodynamically stable, none of them required 
emergency treatment. The most frequent symptom (12 
patients, 67%) was intermittent fever of at least 30 
days duration, seven patients (39%) reported gastro- 
intestinal bleeding: four of them with occult faecal 
blood, and three with a single episode of melaena with 
an average onset 20 days before admittance. Six 
patients (33%) had the classic combination of fever 
and gastrointestinal b eeding; and two also com- 
plained of severe weight loss ( > 6 kg) during the past 
3 months. Eleven patients (61%) also had groin 
symptoms, caused in five cases (42%) by cutaneous 
sinus tracts, in three (25%) by abscesses, and in three 
(25%) by false anastomotic aneurysms, demonstrated 
by ultrasound. (Table 1). 
Apart from abnormal erythrocyte sedimentation 
rates in 15 patients (84%) and abnormal white-cell 
counts in 5 (28%) all patients had biochemical test 
findings, (including red cell count, partial thrombo- 
plastin time, prothrombine time, fibrinogen), within 
normal ranges. Arteriograms were obtained in all 
patients, for planning surgical treatment. CT scans, 
obtained in all subjects at admittance showed that 13 
patients (72%) had evidence of periprosthetic infection 
(gas bubbles, periprosthetic nflammatory reactions) 
but none of them had gross retroperitoneal collections. 
MRI, obtained in eight cases, showed that six patients 
(75%) had evident signs of prosthetic graft infection 
(medium weight intensity on T 1 images and high 
intensity on T2 images); in all 18 patients 99m-Tc scans 
revealed a pathologic accumulation of leukocytes 
along the entire graft (Table 2). The seven patients who 
had previous gastrointestinal b eeding underwent 
gastroduodenoscopy as the first diagnostic inter- 
vention (Table 2). Six of the seven (86%) had aortoen- 
teric erosions in the 3rd to 4th portion of the 
duodenum. Because we found aortoenteric erosions at 
operation in two patients without previous ymptoms 
of gastrointestinal bleeding endoscopy became a 
routine diagnostic procedure in our patients with. 
documented graft infection. 
Blood samples, taken from arm veins, were cultured 
twice; in febrile patients they were cultured at peak 
fever. Despite 3-4 weeks incubation, blood cultures 
invariably yielded negative results. In the eight 
patients who had groin sinus tracts or abscesses, 
preoperative r moval of samples for bacterial culture 
Table 2. Preoperative diagnostic sensitivity of imaging procedures 
in patients with infected abdominal aortic grafts. 
No. correctly 
No. of patients diagnosed (%) 
CT scan 18 
MRI scan 8 
99m-Tc scintigraphy 18 
Gastroduodenoscopy 7 
13(72) 
6(75) 
18(100) 
6(86) 
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allowed the responsible agent to be isolated. Most 
infections (7 patients) were caused by Staphylococcus 
epidermidis, and one by Staphylococcus aureus later 
confirmed by bacterial culture of material from the 
excised graft. All eight positive patients received 
preoperative specific antibiotic therapy (cephalospor- 
ins, ciprofloxacin, imipenem) lasting on average 16 
days (range 8-25 days). The remaining 10 patients 
received broad-spectrum antibiotic therapy (ceph- 
alosporins and metronidazole or imipenem). In all 
cases antibiotic therapy resolved the fever and slightly 
reduced the erythrocyte sedimentation rate. In four 
cases a repeat 99m-Tc scan, obtained 7 days later, 
showed an unchanged leukocyte accumulation. 
Perioperative management 
The basic operative procedure comprised excision of 
the prosthetic graft and immediate in situ replacement 
with a standard polytetrafluorethylene (PTFE) graft. 
An infrarenal clamp was used in 88% and a suprarenal 
clamp in 12%. Nine patients had aortoenteric erosions. 
In these patients, before vascular intervention, the 
duodenal lesion was repaired, in six cases by simple 
suture and in three cases by a resection of a third part 
of the duodenum and end-to-end intestinal 
anastomosis. 
None of the infected prosthetic grafts adhered 
closely to the surrounding tissues, none had unduly 
large purulent collections, and none of the proximal 
aortic anastomoses showed signs of suture-line dehis- 
cence. Intraoperative microscopic examination of sam- 
ples from periprosthetic tissues confirmed aspecific 
infection but provided few guidelines to the operative 
strategy. Twelve specimens contained leukocytes, four 
showed small numbers of Gram-positive cocci and 
two had Gram-negative bacilli. Although the bacterio- 
logic findings obtained from examination of arterial- 
wall fragments, periprosthetic tissue and tissue from 
various parts of the excised graft eventually provided 
more specific findings, these results did not become 
available until some days after surgery. 
Before in situ placement of the new graft, surround- 
ing necrotic tissues and sinus tracts were debrided as 
thoroughly as possible before the field was washed 
repeatedly with an antiseptic solution containing 2% 
povidine-iodine. In all cases the operation concluded 
with in situ replacement of the excised graft with a 
new PTFE prosthesis, by means of an end-to-end 
anastomosis. To circumvent inguinal sepsis we did 
two aortofemoral transobturator bypasses and in one 
patient we implanted an autologous inguinal prosthe- 
sis constructed from endarterectomised superficial 
femoral artery. In patients with aortoenteric erosions, 
whenever possible we isolated the new prosthesis 
from the duodenum by an omental wrap. All patients 
had retroperitoneal drainage tubes; patients with 
aortofemoral bypass also had inguinal drainage. 
While fluid secretion continued, samples were 
obtained for bacterial cultures to monitor the efficacy 
of antibiotic therapy. Drainage liquid proved bacteri- 
cidal at up to 1/8 dilution. In addition to preoperative 
antibiotic prophylaxis, all patients received intra- 
venous specific antibiotic therapy for 6 weeks post- 
operatively followed by a 2 week course of oral 
therapy. The efficacy of systemic antibiotic therapy 
was monitored with a serumcidal titre test (Schlichter 
test) .16 
Results 
Two of the 18 patients who underwent in situ 
replacement of aortic abdominal prosthetic grafts died 
during the postoperative course: the first on the 2nd 
postoperative day after a myocardial infarction and 
the other, a patient who had an aortoenteric erosion, 
on the 19th postoperative day because of haemor- 
rhagic shock. Autopsy revealed dehiscence of the 
proximal anastomosis. 
None of the remaining 16 operations resulted in 
perioperative deaths, none of the prostheses throm- 
bosed and no amputations were needed. 
Cultures of material removed from the eight 
patients with sinus tracts and inguinal abscesses 
confirmed the preoperative bacteriologic findings. In 
the other 10 patients, the following bacteria were 
isolated: Staphylococcus epidermidis associated with 
Escherichia coli in two cases; Staphylococcus aureus in 
five patients with coexisting Escherichia coli in two; one 
patient had Serratia marcescens and another had a 
polymicrobial ssociation (Proteus mirabilis, Bacteroides 
frag~lis and Escherichia coli). One patient had negative 
cultures (Table 3). 
Table 3. Microrganisms cultured from patients with infected 
abdominal ortic grafts. 
No. of 
Bacterial organisms patients (%) 
Staphylococcus epiderrnidis (alone) 7 (39) 
Staphylococcus a reus (alone) 4 (22) 
Staphylococcus epidermidis + Escherich iacol i 2 (11) 
Staphylococcus a reus +Escherichia coli 2 (11) 
Serratia marcescens 1 (6) 
Escherichia Coli+ Proteus mirabilis+ 
Bacteroidesfragilis 1 (6) 
No growth 1 (6) 
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Table 4. Charcteristics of patients with Perigraft infection. 
Patient Original g ra f t  Symptoms Graft cultures Surgical treatment Outcome (follow-up) 
1 Aortofemoral Groin abscess Staph. EPI PTFE in situ replacement Uneventful (40 months) 
2 Aortobifemoral Groin false aneurysm Staph. EPI PTFE in situ replacement Uneventful (43 months) 
3 Aortobifemoral Groin sinus Staph. EPI PTFE in situ replacement Uneventful (44 months) 
4 Aortobifemoral Groin abscess, fever Staph. EPI PTFE in situ replacement Uneventful (39 months) 
5 Aortoaortic Fever Staph. aureus PTFE in situ replacement Uneventful (42 months) 
6 Aortobifemoral Groin false aneurysm Staph. EPI PTFE in situ replacement Uneventful (36 months) 
7 Aortobifemoral Groin false aneurysm No growth PTFE in situ replacement Uneventful (39 months) 
8 Aortobifemoral Groin abscess, fever .Staph: EPI ; :~  PTFE in situ replacement Uneventful (12 months) 
9 Aortobifemoral Groin sinus, feve r ~ Staph..EPI PTFE in situ replacement Uneventful (44 months) 
Staph. EPI: Coagulase-negative Staphylococcus epidermidis 
Postoperative follow-up studies included 3 monthly 
clinical assessments, a 6 monthly CT and 99m-Tc scan 
for the first year and yearly thereafter. During a mean 
follow-up of 37 months (range 8-59 months) none of 
the 16 patients who survived had infective graft- 
related complications. Two patients needed throm- 
bectomy for occlusion of a prostheses, one patient at 4 
months and the other at 12 months after surgery. One 
patient died of lung cancer 44 months after in s i tu  
replacement with no evidence of graft complications. 
Discussion 
The patients undergoing in  s i tu  replacement of 
infected abdominal aortic grafts reviewed in this 
retrospective study reflect the clinical diversity typi- 
cally seen in a specialised vascular surgical depart- 
ment. Over the years, numerous proposals have been 
made for the ideal treatment of aortic grafts infections. 
Some reports have described occasional successes 
with conservative management consisting of drainage 
of the pus (with ultrasound- or CT-guided needle 
aspiration) followed by antibiotic therapy directed 
against he specific responsible micro-organism. I7 An 
alternative conservative approach requiring minimal 
surgery with aggressive, long-term antibiotic treat- 
ment led to a successful outcome in most of the 
patients treated. 18 As a temporary procedure before 
definitive treatment, others 19 have suggested cross- 
femoral autologous grafts in aortofemoral graft infec- 
tions. But the most widely accepted surgical proce- 
dure is excision of the infected graft, ligature of the 
aorta and extra-anatomic revascularisation of the 
lower limbs. Although this treatment has undoubtedly 
improved results room for further improvement 
remains. However, these procedures are technically 
complex, they entail lengthy operating times, and 
usually have to be done as emergencies, often in 
patients in compromised general conditions. 7'13'2° 
They also have a high risk of late complications 
including dehiscence of the aortic ligature or forma- 
tion of false aortic aneurysms. 6'21 Extra-anatomic 
Table 5. Charcteristics of patients with aortoenteric erosions. 
Patient Original graft Symptoms Graft cultures Surgical treatment Outcome (follow-up) 
1 Aortoaortic GI bleeding, fever Staph. aureus PTFE in situ replacement Died of lung cancer 
(44 months postop.) 
2 Aortobifemoral GI bleeding, roin sinus Staph. EPI+E. coli PTFE in situ replacement Uneventful (27 months) 
+TO bypass 
3 Aortobifemoral Groin sinus, fever Staph. EPI+E. coli PTFE in situ replacement Died 2nd postop, day 
(myocardial nfarction) 
4 Aortofemoral GI bleeding, fever Staph. aureus PTFE in situ replacement Uneventful (59 months) 
+Endar. SFA 
5 Aortobiiliac GI bleeding, fever Serratia marcescens PTFE in situ replacement Uneventful (33 months) 
6 Aortobifemoral GI bleeding, roin sinus, fever Staph. aureus+E, coli PTFE in situ replacement Uneventful (32months) 
+TO bypass 
7 Aortoaorfic GI bleeding, fever Staph. aureus+E, coli PTFE in situ replacement Uneventful (47 months) 
8 Aortoaortic GI bleeding, fever Pr. mirabilis PTFE in situ replacement Died 19th postop, day 
Bact. fragilis, E. coli (haemorrhagic shock) 
9 Aortoaortic Fever Staph. aureus PTFE in situ replacement Uneventful (8months) 
Gh gastrointestinal; Staph. EPI: Coagulase-negative. 
TO bypass: Trans-obturatory bypass. 
Endar. SFA: Endarterectomised superficial femoral artery. 
Pr. mirabilis: Proteus mirabilis; Bact. fragilis: Bacteroides fragilis. 
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revascularisation itself also carries a risk of complica- 
tions related to the prosthetic implant (including 
thrombosis, infection, and embolisation). Reaching 
reported rates as high as 40% of these complications 
often lead to loss of limbs. 22'23 
Encouraged by the positive results obtained in 
patients operable only by in situ graft replacement (for 
example those needing raft reconstruction for supra- 
renal or mycotic aneurysms), 24"25 in 1987 Vollmar et 
al. 1° and Walker et al. 11 reproposed this more con- 
servative technique for treating aorto-enteric fistulae. 
Comparing these two procedures, Vollmar et al. 
reported that in situ replacement yielded better esults 
(26%) than the conventional procedure (52%). In the 
same year, Walker et al. reported a survival rate of 80% 
in a case series of 23 patients with aortoenteric fistulae 
treated by in situ replacement of the infected graft. 
They underlined the importance of the significant 
association between severe sepsis and death. The 
mortality rate reached 60% in patients with retro- 
peritoneal abscesses yet only 22% in patients with no 
pus or only smaller collections. In a retrospective 
review published in 1991 and referring to 18 patients 
with double-velour Dacron infected grafts replaced 
with grafts of the same material, Jacobs et al. 12 noted 
that mortality rates and graft reinfection related 
strictly to the grade of infection. Patients with severe 
infection had a mortality rate of 83% and a reinfection 
rate of 100%; whereas patients with low-grade infec- 
tion had a mortality of nil and only one patient had 
graft reinfection. Describing acase series of 11 patients 
who had aortic infection in various anatomic locations 
(mycotic aneurysms and secondary aortoenteric fistu- 
lae) treated by graft replacement in situ, and a mean 
5-year follow-up, Robinson et al. 13 reported a survival 
rate of 100%. They also suggested that antibiotic 
therapy should be continued for at least 6 weeks and 
concurred with others 11'12 in concluding that infected 
abdominal grafts should be treated by in situ graft 
replacement only if sepsis is localised to the aorta, 
without overt retroperitoneal collections. In a later 
study addressed to the indications for in situ graft 
replacement, Bandyk et al. 14 extended the criteria from 
clinical to bacteriological. Reporting a series of 15 
patients with aortofemoral graft infections and a mean 
follow up of 21 months they concluded that in situ 
replacement--even if limited to replacement of a 
branch of the graft--was indicated only for patients 
with coagulase-negative Staphylococcus epidermididis 
infections. Other reports later described in situ graft 
replacements in patients with infections caused by 
micro-organisms other than coagulase-negative Staph- 
ylococcus epidermididis, including Staphylococcus aureus 
and Escherichia coli. Torsello et al. 26 have reported the 
results obtained in three patients with Staphylococcus 
aureus infections in whom other revascularisation 
methods were deemed unfeasible and who received in 
situ replacement with rifampicin-impregnated pros- 
theses. Calligaro et al. 15 described a series of 42 
patients with graft infections, 33 identified in bacterio- 
logic cultures as Gram-positive and 22 as Gram- 
negative. They concluded that graft infections caused 
by Gram-negative and Gram-positive micro-organ- 
isms other than Pseudomonas could be safely treated by 
in situ replacement provided that periprosthetic nec- 
rotic tissues were thoroughly debrided and patients 
received prolonged antibiotic therapy. Despite being 
responsible for less than 10% of graft infections, 
Pseudomonas i  an unusually aggressive micro-organ- 
ism, which causes dehiscence of the suture lines even 
in grafts constructed from autologous material. 15'27 
The published findings indicate that the feasibility of 
in situ replacement rests on two guiding principles, 
namely the clinical criteria and the bacteriological 
indications dictated by the specific pathogenic agent. 
Whereas the majority seem to agree that the clinical 
criteria preclude in situ replacement in patients with 
systemic signs and localised foci of severe infection, 
the bacteriological criteria for this option remain 
debatable. All agents, except coagulase-negative 
Staphylococcus epidermididis, remain under discussion. 
An evident problem with preoperative bacteriologi- 
cal testing is that cultures, for identifying the responsi- 
ble pathogenic agent, can often be obtained only in 
patients with infected sinus tracts or groin abscesses. 
Intraoperative Gram staining of the infected excised 
specimen is equally unsatisfactory because it merely 
identifies the presence of leukocytes, cocci or bacilli 
without specifying the species. Because the definitive 
results of bacteriologic dentification i cultures from 
the excised specimen rarely become available until 
days after the operation, the indications for in situ 
graft replacement often depend on clinical criteria 
alone, together with an absence of extensive retro- 
peritoneal collections on CT scanning. In our patients 
the causative agent was diagnosed either by preopera- 
tive (8 cases) or postoperative cultures (10 cases). Our 
follow-up data suggests that the type of micro- 
organism did not influence the surgical outcome. 
However, one patient, who had an aortoenteric ero- 
sion, died 19 days after surgery because of haemor- 
rhagic shock secondary to dehiscence of the proximal 
anastomosis. In this case, because intraoperative Gram 
staining showed the presence of leukocytes alone, and 
because we found no purulent retroperitoneal collec- 
tions we decided to do an in situ graft replacement. 
This patient's death was probably due to the excep- 
tionally virulent bacterial "cocktail" (Proteus mirabilis, 
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Bacteroides fragilis and Escherichia coli) isolated from the 
graft after incubation lasting 14 days. A likely reason 
for this lengthy incubation was the prolonged preop- 
erative antibiotic therapy of more than 60 days. 
From a technical standpoint, even in patients with 
clinical symptoms limited to the groin, we based our 
decision to undertake total graft excision less on 
clinical data and more on 99-m Tc scintigraphic 
evidence of leukocyte uptake at the proximal anasto- 
mosis. This finding was later confirmed by bacterio- 
logical cultures. Radical excision of the graft may be 
one reason why none of our patients had the post- 
operative infections commonly reported in other 
series 11'3°'3~ referring to patients with aortobifemoral 
bypass and signs of localised groin infection treated by 
partial resection of the infected branch and in situ 
replacement. Follow-up studies showed that these 
recurrent postoperative infections of the aortic portion 
of the original prosthetic graft had an incidence 
ranging from 9.5 to 15%. 
Although the ideal material for in situ replacement 
grafts remains controversial, most vascular sur- 
geons 11-13 use Dacron grafts. Recent papers have 
described the experimental nd clinical use of Dacron 
prostheses impregnated with rifampicin. 26'32 In 1991 
Bahnini et al., 33 described the first case of an infected 
aortic graft replaced with an aortic prosthesis con- 
structed using cryopreserved aorta from a cadaver. In 
1994 these investigators eported a case series of 58 
patients with infected aortic grafts treated by this 
procedure. 34 The immediate results obtained after 
transplanting the homologous tissue indicated a peri- 
operative mortality of 13.8%, with no major amputa- 
tions. During long term follow-up (mean 19.6 _+ 14.0 
months) only one patient died because of reinfection; 
whereas 24% of the patients had aortic dilation, iliac- 
bifemoral lesions or other graft-related complications. 
If the immunologic problems that probably underlie 
these complications can be solved, these allografts 
may in future be preferred to synthetic grafts. In 1995, 
Nevelsteen etat. 35 reported autogenous reconstruction 
with the superficial femoral vein in 12 patients with 
prosthetic nfection after aorto (ilio)femoral grafting. A
mean 17 months follow-up showed no reinfections, 
one occluded graft, and minimal disability from 
removal of the deep veins. 
Since 1989 we have used PTFE grafts because the 
bacteria that most commonly cause primary graft 
infections adhere much less easily to PTFE than to 
Dacron. 36 During the 37 month follow-up no patients 
had signs compatible with graft reinfection. Our 
protocol for surveillance of patients with in situ 
replacement of prosthetic grafts consisted of 3 
monthly clinical assessments, 6 monthly CT scan and 
99m-Tc scan for the first year, and yearly assessments 
thereafter. We have found 99m-Tc scan a particularly 
reliable diagnostic technique for assessing raft infec- 
tion. 37 It has the notable advantage of revealing the 
earliest signs of bacterial contamination after 
grafting. 38-4° 
In conclusion, although an infected abdominal 
aortic prosthetes still remains a severe vent, surgical 
treatment offers patients better prospects now than in 
the past. However, the improved surgical outcome 
remains trictly related to the timeliness of diagnosis 
and to the grade of clinical severity. In patients with 
low-grade graft infections in situ replacement surgery 
has an excellent chance of success. 
Infections caused by coagulase-negative Staphylo- 
coccus epidermidis and other bacteria can be success- 
fully treated by in situ graft replacement. However, 
graft infections due to aggressive or mixed bacterial 
strains still portend an exceedingly poor prognosis. 
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